Accurate detection of Newcastle disease virus using proximity-dependent DNA aptamer ligation assays.
Newcastle disease virus
aptamers
proximity ligation assays
rRT-PCR
sandwich ELAA
Journal
FEBS open bio
ISSN: 2211-5463
Titre abrégé: FEBS Open Bio
Pays: England
ID NLM: 101580716
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
revised:
28
01
2021
received:
16
12
2020
accepted:
15
02
2021
pubmed:
18
2
2021
medline:
7
1
2022
entrez:
17
2
2021
Statut:
ppublish
Résumé
Detecting viral antigens at low concentrations in field samples can be crucial for early veterinary diagnostics. Proximity ligation assays (PLAs) in both solution and solid-phase formats are widely used for high-performance protein detection in medical research. However, the affinity reagents used, which are mainly poly- and monoclonal antibodies, play an important role in the performance of PLAs. Here, we have established the first homogeneous and solid-phase proximity-dependent DNA aptamer ligation assays for rapid and accurate detection of Newcastle disease virus (NDV). NDV is detected by a pair of extended DNA aptamers that, upon binding in proximity to proteins on the envelope of the virus, are joined by enzymatic ligation to form a unique amplicon that can be sensitively detected using real-time PCR. The sensitivity, specificity, and reproducibility of the assays were validated using 40 farm samples. The results demonstrated that the developed homogeneous and solid-phase PLAs, which use NDV-selective DNA aptamers, are more sensitive than the sandwich enzymatic-linked aptamer assay (ELAA), and have a comparable sensitivity to real-time reverse transcription PCR (rRT-PCR) as the gold standard detection method. In addition, the solid-phase PLA was shown to have a greater dynamic range with improved lower limit of detection, upper- and lower limit of quantification, and minimal detectable dose as compared with those of ELAA and rRT-PCR. The specificity of PLA is shown to be concordant with rRT-PCR.
Identifiants
pubmed: 33595202
doi: 10.1002/2211-5463.13117
pmc: PMC8016122
doi:
Substances chimiques
Aptamers, Nucleotide
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1122-1131Informations de copyright
© 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.
Références
Clin Chem. 2006 Jun;52(6):1152-60
pubmed: 16723682
Science. 1992 Oct 2;258(5079):120-2
pubmed: 1439758
Mol Cell Proteomics. 2010 Feb;9(2):327-35
pubmed: 19955079
J Clin Microbiol. 1983 Oct;18(4):930-4
pubmed: 6630472
Methods Mol Biol. 2009;504:385-98
pubmed: 19159107
J Clin Microbiol. 2004 Jan;42(1):329-38
pubmed: 14715773
BMC Neurosci. 2010 Oct 05;11:124
pubmed: 20923550
Essays Biochem. 2019 Oct 16;63(4):433-456
pubmed: 31652314
Clin Chem. 2005 Sep;51(9):1605-11
pubmed: 16002456
Clin Chem. 2009 Apr;55(4):611-22
pubmed: 19246619
Onderstepoort J Vet Res. 2001 Jun;68(2):131-4
pubmed: 11585090
J Virol. 1973 Feb;11(2):263-71
pubmed: 4734650
Vet Microbiol. 2019 Jan;228:53-60
pubmed: 30593380
Rev Sci Tech. 2000 Aug;19(2):443-62
pubmed: 10935273
Virol J. 2009 Dec 07;6:217
pubmed: 19968865
Sci Rep. 2016 Sep 29;6:34358
pubmed: 27681459
J Virol. 2012 May;86(10):5730-41
pubmed: 22438532
Sci Rep. 2016 Nov 11;6:36890
pubmed: 27833149
Nat Biotechnol. 2002 May;20(5):473-7
pubmed: 11981560
J Virol. 2002 Feb;76(4):1816-24
pubmed: 11799177
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3067-72
pubmed: 17360610
Analyst. 2009 Sep;134(9):1896-901
pubmed: 19684916
Proc Natl Acad Sci U S A. 2011 May 24;108(21):8809-14
pubmed: 21555566
Nat Commun. 2019 Aug 26;10(1):3854
pubmed: 31451692
Clin Chem. 1999 Sep;45(9):1628-50
pubmed: 10471678
N Biotechnol. 2018 Oct 25;45:51-59
pubmed: 29101055
Biol Chem. 2006 Jun;387(6):769-72
pubmed: 16800738
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14920-5
pubmed: 21873198
Vet Microbiol. 2008 Mar 18;127(3-4):227-36
pubmed: 17897794
J Immunol Methods. 2002 Mar 1;261(1-2):167-75
pubmed: 11861075
Curr Protoc Mol Biol. 2015 Jan 05;109:20.10.1-20.10.25
pubmed: 25559104
PLoS One. 2020 Aug 13;15(8):e0237253
pubmed: 32790805
Prion. 2014;8(3):261-5
pubmed: 25482604